Related Experiment Video
Updated: May 10, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis
Jan Novák1, Jan Vinklárek, Julie Bienertová-Vašků
1Faculty of Medicine, Department of Physiology, Masaryk University, Brno, Czech Republic; Faculty of Medicine, Department of Pathological Physiology, Masaryk University, Brno, Czech Republic.
Abstract:
MicroRNAs (miRs) are small non-coding RNAs known to fulfill various functions in tissue development, function, and pathogenesis of various diseases, including cancer. Rhabdomyosarcoma (RMS) represents the most common soft tissue tumor in the pediatric population. miRs have been shown to play important roles in RMS pathogenesis and some of the studies suggest their potential as diagnostic, prognostic, and even therapeutic tools facilitating better management of this disease. This review summarizes current information about the role of miRs in the development of normal skeletal muscle and their deregulation in RMS.
Insights
MicroRNAs (miRs) are small molecules crucial for muscle development and cancer. This review explores their role in normal skeletal muscle and their dysregulation in pediatric rhabdomyosarcoma (RMS).
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRs) are small non-coding RNAs regulating gene expression.
- They are vital for tissue development, function, and disease pathogenesis, including cancer.
- Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue tumor.
Purpose of the Study:
- To review the current understanding of microRNA roles in normal skeletal muscle development.
- To summarize the involvement and deregulation of microRNAs in rhabdomyosarcoma pathogenesis.
- To highlight the potential of miRs as diagnostic, prognostic, and therapeutic tools for RMS.
Main Methods:
- Literature review of studies on microRNAs in skeletal muscle and rhabdomyosarcoma.
- Analysis of existing data on microRNA expression patterns in normal and cancerous tissues.
- Synthesis of information regarding the functional impact of miRs in RMS development.
Main Results:
- MicroRNAs are key regulators of skeletal muscle differentiation and homeostasis.
- Specific miRs are frequently deregulated in rhabdomyosarcoma, impacting tumor initiation and progression.
- Altered miR profiles correlate with distinct RMS subtypes and clinical outcomes.
Conclusions:
- MicroRNAs play a significant role in both normal muscle development and rhabdomyosarcoma.
- Deregulation of miRs contributes to the pathogenesis of this pediatric cancer.
- Targeting miRs presents a promising avenue for novel diagnostic and therapeutic strategies in RMS management.
Related Concept Videos
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Satellite Stem Cells and Muscular Dystrophy

